You are here: Home → FDA Draft Guidance for Monitoring
 
Document Actions
  • Send this page to somebody
  • Print this page

FDA Draft Guidance for Monitoring

Last modified October 07, 2011 09:05 AM - EST

The FDA has published a draft guidance document regarding the use of a risk-based approach to monitoring.  Click here to see the document.  Of note, results from the CTTI monitoring project were acknowledged within the draft guidance.
News
Summaries Available - Workshop on Quality-by-Design in Clinical Trials February 28, 2012 - EST
CTTI Executive Director Authors Paper on Impediments to Clinical Research February 21, 2012 - EST
New FDA Guidance on Collection of Safety Data February 10, 2012 - EST
More…
« March 2012 »
Su Mo Tu We Th Fr Sa
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31


 

This site conforms to the following standards:

  • Powered by Plone, the Open Source Content Management System
  • Section 508
  • WCAG
  • Valid XHTML
  • Valid CSS
  • Usable in any browser

Related Links

Resource Links